BeOne Medicines AG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	30,028	33,678	19,712	18,862	22,944	27,818
Market Cap Growth	17.66%	70.85%	4.51%	-17.79%	-17.52%	17.53%
Enterprise Value	26,371	31,053	18,147	16,584	18,981	21,873
Last Close Price	270.10	303.81	184.71	180.36	219.94	270.93
PE Ratio	59.79	123.00	-	-	-	-
Forward PE	38.01	66.95	-	-	-	-
PS Ratio	5.26	6.30	5.17	7.67	16.20	23.65
PB Ratio	6.27	7.72	5.92	5.33	5.23	4.54
P/TBV Ratio	6.50	7.90	5.84	5.32	5.18	4.10
P/FCF Ratio	25.02	35.76	-	-	-	-
P/OCF Ratio	22.21	29.87	-	-	-	-
EV/Sales Ratio	4.62	5.81	4.76	6.74	13.41	18.60
EV/EBITDA Ratio	32.10	52.74	-	-	-	-
EV/EBIT Ratio	38.58	69.45	-	-	-	-
EV/FCF Ratio	21.97	32.97	-	-	-	-
Debt / Equity Ratio	0.41	0.44	0.32	0.26	0.13	0.11
Debt / EBITDA Ratio	2.46	3.40	-	-	-	-
Debt / FCF Ratio	1.84	2.12	-	-	-	-
Net Debt / Equity Ratio	-0.57	-0.58	-0.46	-0.64	-0.90	-0.97
Net Debt / EBITDA Ratio	-3.28	-4.33	3.90	2.01	2.29	4.25
Net Debt / FCF Ratio	-2.46	-2.70	2.44	1.31	2.16	3.79
Asset Turnover	0.69	0.76	0.65	0.40	0.19	0.17
Inventory Turnover	1.04	1.21	1.30	1.09	1.09	0.99
Quick Ratio	3.16	2.96	1.49	1.96	3.21	4.44
Current Ratio	3.64	3.41	1.80	2.32	3.55	4.76
Return on Equity (ROE)	11.25%	7.46%	-18.77%	-22.26%	-38.11%	-29.15%
Return on Assets (ROA)	6.42%	4.36%	-11.72%	-21.17%	-24.52%	-20.63%
Return on Invested Capital (ROIC)	24.10%	12.00%	-25.75%	-60.23%	-102.18%	-102.75%
Return on Capital Employed (ROCE)	10.47%	8.88%	-14.76%	-27.12%	-30.21%	-25.11%
Earnings Yield	1.78%	0.81%	-	-	-	-
FCF Yield	4.00%	2.80%	-	-	-	-
Buyback Yield / Dilution	-10.10%	-7.75%	-0.86%	-1.22%	-11.15%	-11.16%
Total Shareholder Return	-10.10%	-7.75%	-0.86%	-1.22%	-11.15%	-11.16%

SEC Filings: 10-K · 10-Q